Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference
December 06 2018 - 4:05PM
Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage
medical dermatology and aesthetics company, today announced that
Frederick C. Beddingfield III, M.D., Ph.D., President and Chief
Executive Officer of Sienna, is scheduled to participate in a
fireside chat at the BMO Capital Markets Prescriptions for Success
Healthcare Conference, Wednesday, Dec. 12, 2018, 10:20 a.m. Eastern
Time, in New York.
The presentation will be webcast live and can be
accessed through the Investor Relations section of the Company’s
website at Investors.SiennaBio.com. An archived version of the
webcast will be available approximately two hours following the
live presentation for 90 days.
About Sienna Biopharmaceuticals
Sienna Biopharmaceuticals, Inc. is a
clinical-stage biopharmaceutical company focused on bringing
innovations in biotechnology to the discovery, development and
commercialization of first-in-class, targeted, topical products in
medical dermatology and aesthetics. The Company’s objective is to
develop a unique, diversified, multi-asset pipeline of topical
therapies that enhance the health, appearance and quality of life
of dermatology and aesthetics patients. Sienna is led by a
management team with extensive experience in product development
and commercialization at several leading dermatology, aesthetics
and biotechnology companies.
For more information, visit the Company’s
website at www.SiennaBio.com.
Contact:
InvestorsSean
Andrewssandrews@siennabio.com818-629-2244
MediaCaroline Van
Hovecvanhove@siennabio.com818-575-6250
Crystal Muilenburgcmuilenburg@siennabio.com818-584-1035
Sienna Biopharmaceuticals (NASDAQ:SNNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sienna Biopharmaceuticals (NASDAQ:SNNA)
Historical Stock Chart
From Apr 2023 to Apr 2024